BCRX
#1832
BioCryst Pharmaceuticals, Inc. - Common Stock
9.9 2 USD
+0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+2.27%
Changement Mensuel
+10.22%
Evolution sur 6 mois
+16.57%
Changement Annuel
+19.95%
Clôture Précédente
9.7 0
Open
9.9 2
Low
9.9 2
High
9.9 2
Volume
106
Financials
- Market Capitalization 2.53 B
- Employee 435
- Founded 1986
- CEO Jon P. Stonehouse
- Website www.biocryst.com
- Headquarter Delaware, United States
- FIGI BBG000BLYWX6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.71
ratio cours/chiffre d'affaires
2.47
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1810 |  VRDN Viridian Therapeutics, Inc. - Common Stock | 23.03 USD | -0.56% | -4.68% | +22.50% | +2.58% | 2.61 B USD | ||
| 1826 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 25.81 USD | +2.38% | -2.82% | +3.57% | -19.32% | 2.54 B USD | ||
| 1847 |  VERA Vera Therapeutics, Inc. - Class A Common Stock | 34.23 USD | +0.44% | -2.48% | +7.57% | +15.10% | 2.47 B USD | ||
| 1850 |  PGEN Precigen, Inc. - Common Stock | 6.86 USD | -1.01% | -9.50% | +10.11% | +42.62% | 2.46 B USD |